Overview

Study Evaluating Tigecycline Versus Ceftriaxone In Complicated Intra-Abdominal Infections & Community Acquired Pneumonia

Status:
Withdrawn
Trial end date:
2014-05-01
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to compare the safety of tigecycline versus a ceftriaxone regimen in pediatric subjects (aged 8 to 17 years) with complicated intra-abdominal infections (cIAI) and community acquired pneumonia (CAP).
Phase:
Phase 3
Details
Lead Sponsor:
Pfizer
Treatments:
Amoxicillin-Potassium Clavulanate Combination
Ceftriaxone
Clarithromycin
Metronidazole
Minocycline
Tigecycline